237 related articles for article (PubMed ID: 26530792)
1. New Molecular and Cellular Mechanisms of Tolerance: Tolerogenic Actions of IL-2.
Pérol L; Piaggio E
Methods Mol Biol; 2016; 1371():11-28. PubMed ID: 26530792
[TBL] [Abstract][Full Text] [Related]
2. Fine tuning subsets of CD4
Zhao Z; Zhang X; Su L; Xu L; Zheng Y; Sun J
Int Immunopharmacol; 2018 Mar; 56():269-276. PubMed ID: 29414661
[TBL] [Abstract][Full Text] [Related]
3. Effector T cells boost regulatory T cell expansion by IL-2, TNF, OX40, and plasmacytoid dendritic cells depending on the immune context.
Baeyens A; Saadoun D; Billiard F; Rouers A; Grégoire S; Zaragoza B; Grinberg-Bleyer Y; Marodon G; Piaggio E; Salomon BL
J Immunol; 2015 Feb; 194(3):999-1010. PubMed ID: 25548233
[TBL] [Abstract][Full Text] [Related]
4. IL-2 promotes the function of memory-like autoregulatory CD8+ T cells but suppresses their development via FoxP3+ Treg cells.
Shameli A; Yamanouchi J; Tsai S; Yang Y; Clemente-Casares X; Moore A; Serra P; Santamaria P
Eur J Immunol; 2013 Feb; 43(2):394-403. PubMed ID: 23180662
[TBL] [Abstract][Full Text] [Related]
5. Crosstalk of regulatory T cells and tolerogenic dendritic cells prevents contact allergy in subjects with low zone tolerance.
Luckey U; Schmidt T; Pfender N; Romer M; Lorenz N; Martin SF; Bopp T; Schmitt E; Nikolaev A; Yogev N; Waisman A; Jakob T; Steinbrink K
J Allergy Clin Immunol; 2012 Sep; 130(3):781-797.e11. PubMed ID: 22935591
[TBL] [Abstract][Full Text] [Related]
6. T-cell tolerance and the multi-functional role of IL-2R signaling in T-regulatory cells.
Cheng G; Yu A; Malek TR
Immunol Rev; 2011 May; 241(1):63-76. PubMed ID: 21488890
[TBL] [Abstract][Full Text] [Related]
7. Harnessing the power of regulatory T-cells to control autoimmune diabetes: overview and perspective.
Yu H; Paiva R; Flavell RA
Immunology; 2018 Feb; 153(2):161-170. PubMed ID: 29155454
[TBL] [Abstract][Full Text] [Related]
8. Low-dose IL-2 therapy in autoimmune diseases: An update review.
Zhang R; Zhao Y; Chen X; Zhuang Z; Li X; Shen E
Int Rev Immunol; 2024 May; 43(3):113-137. PubMed ID: 37882232
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy.
Liao W; Lin JX; Leonard WJ
Immunity; 2013 Jan; 38(1):13-25. PubMed ID: 23352221
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneous CD3 expression levels in differing T cell subsets correlate with the in vivo anti-CD3-mediated T cell modulation.
Valle A; Barbagiovanni G; Jofra T; Stabilini A; Perol L; Baeyens A; Anand S; Cagnard N; Gagliani N; Piaggio E; Battaglia M
J Immunol; 2015 Mar; 194(5):2117-27. PubMed ID: 25646305
[TBL] [Abstract][Full Text] [Related]
11. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease.
Sakaguchi S; Ono M; Setoguchi R; Yagi H; Hori S; Fehervari Z; Shimizu J; Takahashi T; Nomura T
Immunol Rev; 2006 Aug; 212():8-27. PubMed ID: 16903903
[TBL] [Abstract][Full Text] [Related]
12. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases.
Sakaguchi S; Sakaguchi N; Asano M; Itoh M; Toda M
J Immunol; 1995 Aug; 155(3):1151-64. PubMed ID: 7636184
[TBL] [Abstract][Full Text] [Related]
13. How GRAIL controls Treg function to maintain self-tolerance.
Fathman CG; Yip L; Gómez-Martín D; Yu M; Seroogy CM; Hurt CR; Lin JT; Jenks JA; Nadeau KC; Soares L
Front Immunol; 2022; 13():1046631. PubMed ID: 36569931
[TBL] [Abstract][Full Text] [Related]
14. The immunology of pregnancy: regulatory T cells control maternal immune tolerance toward the fetus.
La Rocca C; Carbone F; Longobardi S; Matarese G
Immunol Lett; 2014 Nov; 162(1 Pt A):41-8. PubMed ID: 24996040
[TBL] [Abstract][Full Text] [Related]
15. Treg cells in autoimmunity: from identification to Treg-based therapies.
Göschl L; Scheinecker C; Bonelli M
Semin Immunopathol; 2019 May; 41(3):301-314. PubMed ID: 30953162
[TBL] [Abstract][Full Text] [Related]
16. Beyond regulatory T cells: the potential role for IL-2 to deplete T-follicular helper cells and treat autoimmune diseases.
Ballesteros-Tato A
Immunotherapy; 2014; 6(11):1207-20. PubMed ID: 25496335
[TBL] [Abstract][Full Text] [Related]
17. Emerging Therapeutics for Immune Tolerance: Tolerogenic Vaccines, T cell Therapy, and IL-2 Therapy.
Moorman CD; Sohn SJ; Phee H
Front Immunol; 2021; 12():657768. PubMed ID: 33854514
[TBL] [Abstract][Full Text] [Related]
18. CD4+CD25+ regulatory T cells: II. Origin, disease models and clinical aspects.
Nielsen J; Holm TL; Claesson MH
APMIS; 2004 Oct; 112(10):642-50. PubMed ID: 15601315
[TBL] [Abstract][Full Text] [Related]
19. Aged regulatory T cells protect from autoimmune inflammation despite reduced STAT3 activation and decreased constraint of IL-17 producing T cells.
Sun L; Hurez VJ; Thibodeaux SR; Kious MJ; Liu A; Lin P; Murthy K; Pandeswara S; Shin T; Curiel TJ
Aging Cell; 2012 Jun; 11(3):509-19. PubMed ID: 22372596
[TBL] [Abstract][Full Text] [Related]
20. The main function of IL-2 is to promote the development of T regulatory cells.
Malek TR
J Leukoc Biol; 2003 Dec; 74(6):961-5. PubMed ID: 12960253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
